Global health strategies show progress but face ongoing hurdles in combating HIV, hepatitis, and STIs

The World Health Organization has released a new assessment of global efforts to control HIV, viral hepatitis, and sexually transmitted infections. While significant strides have been made in expanding prevention and treatment options, the report underscores that persistent challenges remain. One notable development is the growing adoption of long-acting prevention methods, such as lenacapavir, which is now being introduced in multiple countries and planned for wider rollout. These advancements reflect a broader shift toward integrating innovative approaches into public health strategies. However, the report highlights that sustained progress requires stronger coordination, community engagement, and continued investment in research and healthcare infrastructure. Without these measures, the goal of reducing the global burden of these diseases by the end of the decade remains at risk. The findings serve as a call to action for governments, health organizations, and civil society to prioritize these efforts and ensure equitable access to life-saving interventions worldwide. The report’s emphasis on collaboration and innovation signals a critical phase in the fight against these preventable conditions.